The Cytel blog keeps you up to speed with the latest developments in biostatistics and clinical biometrics.

Flexible approaches to Biosimilars Development

March 10, 2017

 At the recent Biosimilars Summit in Philadelphia, Cytel's Pantelis Vlachos presented on statistical challenges and flexible approaches in biosimilar development.  In this blog we summarize some of the challenges and share the slides from talk.

Read More